We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Appoints Laughren Director of New Psychiatry Products Division
FDA Appoints Laughren Director of New Psychiatry Products Division
October 12, 2005
The FDA has appointed Thomas Laughren director of the newly formed Division of Psychiatry Products within the Office of Drug Evaluation I.